Copaxone moves toward Japanese regulatory approval
Posted: Thu Nov 13, 2014 4:12 am
Teva Pharmaceutical Industries Ltd. multiple sclerosis treatment Copaxone is progressing toward regulatory approval in Japan. At the end of 2013, Teva reported a development and marketing agreement with Japan's Takeda Pharmaceutical Co. Ltd. for the Japanese market.
At the time, Teva said that regulatory approval was expected to be received in less than a year. However, nearly a year has passed and no approval has been received......... Read More - http://www.ms-uk.org/copaxone
At the time, Teva said that regulatory approval was expected to be received in less than a year. However, nearly a year has passed and no approval has been received......... Read More - http://www.ms-uk.org/copaxone